Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-06-14

Clinical Trial Update: Reducing 30-Day Sepsis Readmissions: Impact of a Post Discharge Education Program [NA]

View source ↗

Summary

A clinical trial evaluating a post-discharge education program to reduce 30-day sepsis readmissions has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Washington University School of Medicine | Conditions: Sepsis | NA | Status: WITHDRAWN